|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 532 active entries
An SBO Company
PT COQUITLAM BC
Gelogex is relaunched:
We collaborate in nutraceutical discovery:
- Pepto-bioactive delivery in preventative heart health
- PUFA delivery in processed meat, meat-derived and dairy milk foods
The L'Oleo(R) product can be compounded with: casein + cationic proteins + precursors to pepto-bioactive peptides that are delivered upon digestion and proteolysis from the emulsion of fat and protein depending on the meat product (e.g. sausages, luncheon meat, weiners and pate).
Pepto-bioactive type at the level of the endothelial gut lining could encourage the absorptivity of the PUFA via nuclear carriers in the cell during absorption maximizing the amounts of dietary PUFA reaching the liver via the circulation.
The question of stochiometry and rate of formation and effect pepto-bioactive have on HDL vs LDL formation remains, viz.: 1) the carrying capacity for cholesterol esters, 2) the critical role, if any, of PUFA as triacylglycerol (TAG) in HDL vs LDL formation.
The pepto-bioactive fraction could also have an effect on the dynamics of HDL/LDL formation with the given PUFA supply, their circulating half-life or longevity of the species of lipoprotein with their conferring benefit to atherosclerosis and heart health.
Amalgamated fish-based products have here-to-fore not been investigated by Gelogex or manufactured to a wide extent. This is to be investigated further in future including isolating, enriching and producing such pepto-bioactive.
Last update of this entry: May 19, 2019